Arrowhead Pharmaceuticals, Inc. (ARWR)
64.56
-0.44
(-0.68%)
USD |
NASDAQ |
Jan 09, 16:00
65.60
+1.04
(+1.61%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Research and Development Expense (Annual): 585.26M for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 778.47M |
| Eli Lilly & Co. | 10.99B |
| Ionis Pharmaceuticals, Inc. | 901.53M |
| Cidara Therapeutics, Inc. | 71.88M |
| Celcuity, Inc. | 104.20M |